Tower Research Capital LLC (Trc) Indaptus Therapeutics, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $3.68 Billion
- Q3 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Indaptus Therapeutics, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 4,812 shares of INDP stock, worth $4,475. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,812
Previous 4,102
17.31%
Holding current value
$4,475
Previous $8,000
37.5%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding INDP
# of Institutions
18Shares Held
605KCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA256KShares$238,3260.0% of portfolio
-
Investment House LLC Las Vegas, NV100KShares$92,9770.01% of portfolio
-
Geode Capital Management, LLC Boston, MA73.1KShares$68,0090.0% of portfolio
-
Strategy Asset Managers LLC45.3KShares$42,1620.01% of portfolio
-
Pine Valley Investments LTD Liability CO Marlton, NJ44KShares$40,9040.0% of portfolio
About Indaptus Therapeutics, Inc.
- Ticker INDP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 8,258,600
- Market Cap $7.68M
- Description
- Indaptus Therapeutics, Inc., a pre-clinical biotechnology company, develops various anti-cancer and anti-viral immunotherapy products. Its lead clinical oncology candidate is Decoy20 to single agent activity and/or combination therapy-based durable responses of lymphoma, hepatocellular, colorectal, and pancreatic tumors, as well as hepatitis B v...